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The authors of the recent article on increased bone turnover in osteogenesis imperfecta (1) appear to have overlooked a publication of mine (2) in which this question was approached in a different manner. The authors (1) used tetracycline labelling and histomorphometric techniques to show that bone formation rate was increased, as were active osteoclastic and osteoblast surfaces and osteoclast number. My associates and I used a different method to assess bone turnover, namely the rate of release of a "bone-seeker" (in this case, fluoride) in a patient with osteogenesis imperfecta (01) whose fluoride intake was abruptly diminished.
The patient in question, a 6-yr-old boy with severe 01, was treated with NaF [l mg F/(kg.d)] for many years in an attempt to halt the progress of his disease. Based on fluoride balance data, and F content of a bone biopsy we concluded that his body burden of F was about 5 g.
It was finally decided that the fluoride treatment was not effective, and so it was discontinued, and for the subsequent 4' 12 yr a number of 24-h urine samples were obtained for F analysis. Exponential analysis of these data indicated that 10% of his body burden was eliminated with a half-time of 5.4 mo and the remainder with a half-time of 8.9 yr. This latter value is of the same order of magnitude as that observed for F and other "boneseeking" elements in normal subjects. Our data do not support the conclusions of Baron et al. (1) ; rather, they strongly suggest that bone mineral turnover is normal in this disease. In his letter, Dr. Forbes concludes, on the basis of one case of severe osteogenesis imperfecta, that bone mineral turnover is normal in this disease. Our quantitative data unequivocally demonstrate, in a group of nine children with mild 01, that bone formation rates are increased despite a decreased bone volume; therefore, the rate at which trabecular bone is turned over in these patients, considered as a group, is high. These observations accord with the increased hydroxyprolinuria we observed and which has previously been reported in this disease.
The first possible explanation for the discrepancy between Dr. Forbes' results and ours could relate to the type of disease because they were studying a severe case and our patients had only mild 0 1 (Type IA). The second possibility is that even in our group some individual patients had only a marginally increased turnover rate; Dr. Forbes' case could very well be one of these. Third, the data presented in Dr. Forbes' paper on the elimination halftimes for fluoride and other bone seeking agents show normal values varying 10-fold, from 1.3-10 yr in man. This might indicate that either the method lacks precision or that we might not be dealing with only bone mineral turnover but also with some other factors which affect fluoride ion metabolism.
We wonder whether strong conclusions can be drawn from one case, especially because fluoride excretion might reflect other factors as well as resorption or bone turnover. By contrast, our study dealt with a group of nine children and our measurements directly dealt with bone turnover. Our results clearly demonstrate that, as a group, children with Type Ia 0 1 remodel their bone at a high rate relative to their otherwise decreased bone mass.
